共 788 条
- [1] Canalis E(2007)Glucocorticoid-induced osteoporosis: pathophysiology and therapy Osteoporos Int 18 1319-1328
- [2] Mazziotti G(2002)The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis Osteoporos Int 13 777-787
- [3] Giustina A(2007)Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis Curr Rheumatol Rep 9 78-84
- [4] Bilezikian JP(2007)Glucocorticoid-induced osteoporosis: a systematic review and cost–utility analysis Health Technol Assess 11 1-231
- [5] van Staa TP(1996)Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study BMJ 313 344-346
- [6] Leufkens HG(2000)Use of oral corticosteroids in the United Kingdom QJM 93 105-111
- [7] Cooper C(2011)Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW) Bone 49 493-498
- [8] Compston JE(2006)Trends in prevention of glucocorticoid-induced osteoporosis J Rheumatol 33 1651-1657
- [9] Kanis JA(2002)Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice Ann Rheum Dis 61 32-36
- [10] Stevenson M(2000)Oral corticosteroids and fracture risk: relationship to daily and cumulative doses Rheumatology (Oxford) 39 1383-1389